Nuclear factor erythroid 2-related factor 2 (Nrf2) also plays an important role in oxidative stress resistance and anti-inflammation responses, and it is a potential therapeutic target for central nervous system diseases, especially for ischemic stroke (Liu et al., 2019). This evidence concerns the gene NFE2L2 and central nervous system disorder.